EN
Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
BioNTech SE Sponsored ADR $BNTX Shares Sold by TB Alternative Assets Ltd.
Swedbank AB Has $4.92 Million Stake in BioNTech SE Sponsored ADR $BNTX - Stock Observer
Vontobel Holding Ltd. Purchases 10,924 Shares of BioNTech SE Sponsored ADR $BNTX - Markets Daily
BioNTech SE (BNTX) Closes the Acquisition of CureVac N.V.
10 Stocks That Will Go To The Moon in 2026
Other news to note for Dec. 19, 2025 | BioWorld
Hudson Bay Capital Management LP Sells 15,000 Shares of BioNTech SE Sponsored ADR $BNTX
FY2025 EPS Estimates for BioNTech Decreased by HC Wainwright
BioNTech (NASDAQ:BNTX) Price Target Raised to $155.00 - Markets Daily
Gilder Gagnon Howe & Co. LLC Has $71.08 Million Position in BioNTech SE Sponsored ADR $BNTX - Stock Observer
Bellevue Group AG Raises Stake in BioNTech SE Sponsored ADR $BNTX - Daily Political
Research Analysts Set Expectations for BioNTech Q4 Earnings - Markets Daily
Analysts Set BioNTech SE Sponsored ADR (NASDAQ:BNTX) Target Price at $136.42 - Markets Daily
How Recent Developments Are Rewriting The BioNTech Investment Story
Berenberg Bank Forecasts Strong Price Appreciation for BioNTech (NASDAQ:BNTX) Stock
BioNTech SE (BNTX) is a Buy on Lung Cancer Treatment Prospects: Clear Street
Berenberg Bank Issues Positive Forecast for BioNTech (NASDAQ:BNTX) Stock Price - Daily Political
Did New Gotistobart Data Just Shift BioNTech's (BNTX) Oncology-Led Diversification Narrative? - Simply Wall St News
First Trust Advisors LP Has $35.28 Million Holdings in BioNTech SE Sponsored ADR $BNTX
Temasek Holdings Private Ltd Lowers Holdings in BioNTech SE Sponsored ADR $BNTX
Is BioNTech (NasdaqGS:BNTX) Undervalued After Recent Share Price Weakness? A Fresh Look at Its Valuation
BioNTech, OncoC4 presented data from Phase 3 trial for gotistobart | Markets Insider
25,780 Shares in BioNTech SE Sponsored ADR $BNTX Bought by Bollard Group LLC
BioNTech SE Sponsored ADR (NASDAQ:BNTX) Receives Average Rating of "Moderate Buy" from Analysts
BioNTech and OncoC4 Announce Clinically Meaningful Overall Survival Benefit for Selective Treg Modulator Gotistobart in Patients with Previously Treated Squamous Non-Small Cell Lung Cancer
Dodge & Cox Invests $93.42 Million in BioNTech SE Sponsored ADR $BNTX
BioNTech's (BNTX) Buy Rating Reiterated at Jefferies Financial Group
Other news to note for Dec. 4, 2025 | BioWorld
Promising Biotech Stocks To Consider - December 3rd - Markets Daily
The Bull Case For BioNTech (BNTX) Could Change Following Higher Guidance And Oncology Progress - Learn Why
Vaccine stocks slide as FDA official links COVID vaccines and heart conditions in young men | Morningstar
Vaccine stocks take a hit as FDA official points to link between COVID-19 vaccines and rare heart condition in young men | Morningstar
Vaccine makers fall on FDA memo, Bally's wins bid for NYC casino
BioNTech (BNTX): Assessing Valuation Following Recent Momentum Shift
BioNTech (BNTX) Is Up 7.9% After Raising 2025 Revenue Guidance on Bristol-Myers Collaboration
Evaluating BioNTech (BNTX): Is the Stock Undervalued After Its Recent Uptick?
